VASOMOTOR SYMPTOMS
Clinical trials for VASOMOTOR SYMPTOMS explained in plain language.
Never miss a new study
Get alerted when new VASOMOTOR SYMPTOMS trials appear
Sign up with your email to follow new studies for VASOMOTOR SYMPTOMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can this pill cool down menopause hot flashes?
Symptom relief CompletedThis study tested whether a dietary supplement could reduce hot flashes and other menopause symptoms in women aged 40-70. All 112 participants took the supplement daily for 4 weeks, with an option to continue for 8 more weeks. Researchers tracked changes in symptom frequency and …
Matched conditions: VASOMOTOR SYMPTOMS
Phase: NA • Sponsor: Bonafide Health • Aim: Symptom relief
Last updated Apr 02, 2026 14:56 UTC
-
New drug tested for Women's hot flashes
Symptom relief CompletedThis early-stage study tested a new drug called MT-8554 for women experiencing frequent hot flashes. Researchers wanted to see if the drug was safe and how it affected hot flash frequency and body temperature. The study included 24 women who had at least 7 hot flashes per day, in…
Matched conditions: VASOMOTOR SYMPTOMS
Phase: PHASE1 • Sponsor: Tanabe Pharma Corporation • Aim: Symptom relief
Last updated Apr 01, 2026 14:41 UTC
-
New menopause drug shows promise in major trial
Symptom relief CompletedThis large, completed Phase 3 trial tested whether a new hormone called estetrol could safely reduce the frequency and severity of hot flashes and night sweats in postmenopausal women. Over 1,000 women received either estetrol or a placebo for up to a year. The study also looked …
Matched conditions: VASOMOTOR SYMPTOMS
Phase: PHASE3 • Sponsor: Estetra • Aim: Symptom relief
Last updated Mar 27, 2026 12:38 UTC
-
Scientists test new pill forms for hot flash relief
Knowledge-focused CompletedThis study aimed to understand how the body absorbs new pill versions of an experimental drug called elinzanetant, which is being developed to treat hot flashes. Researchers compared how much of the drug got into the bloodstream from a new capsule form versus the original form. T…
Matched conditions: VASOMOTOR SYMPTOMS
Phase: PHASE1 • Sponsor: Bayer • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:43 UTC